The revolutionary UCLA liquid biopsy blood test scans cell-free DNA (cfDNA) in the bloodstream to locate cance! Swipe to see →
Early cancer detection is the most critical factor determining the success of traditional clinical therapies and patient outcomes. Most c...
Cell-free DNA, commonly known as cfDNA, consists of small fragments of genetic material floating freely in the blood plasma. The test uti...
The large-scale application of this method promises to transform the routine of annual physical check-ups in public health systems. The e...
Processing these massive volumes of genomic information requires high-performance artificial intelligence computer models. The algorithms...
The capability to cross-reference genetic data in real-time to diagnose serious illnesses reflects the growing empowerment of patients th...
Liquid biopsy locates the origin of cancer by analyzing specific chemical methylation patterns in cell-free DNA circulating in the blood....
Visit our portal and read the full story!